These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33540022)

  • 1. Solvent-free temperature-facilitated direct extrusion 3D printing for pharmaceuticals.
    Kuźmińska M; Pereira BC; Habashy R; Peak M; Isreb M; Gough TD; Isreb A; Alhnan MA
    Int J Pharm; 2021 Apr; 598():120305. PubMed ID: 33540022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature and solvent facilitated extrusion based 3D printing for pharmaceuticals.
    Dores F; Kuźmińska M; Soares C; Bohus M; A Shervington L; Habashy R; Pereira BC; Peak M; Isreb A; Alhnan MA
    Eur J Pharm Sci; 2020 Sep; 152():105430. PubMed ID: 32562691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment.
    Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA
    Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
    Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
    Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can filaments, pellets and powder be used as feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based additive manufacturing?
    Samaro A; Shaqour B; Goudarzi NM; Ghijs M; Cardon L; Boone MN; Verleije B; Beyers K; Vanhoorne V; Cos P; Vervaet C
    Int J Pharm; 2021 Sep; 607():120922. PubMed ID: 34303815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D printed oral theophylline doses with innovative 'radiator-like' design: Impact of polyethylene oxide (PEO) molecular weight.
    Isreb A; Baj K; Wojsz M; Isreb M; Peak M; Alhnan MA
    Int J Pharm; 2019 Jun; 564():98-105. PubMed ID: 30974194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flexible-dose dispenser for immediate and extended release 3D printed tablets.
    Pietrzak K; Isreb A; Alhnan MA
    Eur J Pharm Biopharm; 2015 Oct; 96():380-7. PubMed ID: 26277660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
    Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA
    Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving drug release rate, drug-polymer miscibility, printability and processability of FDM 3D-printed tablets by weak acid-base interaction.
    Patel NG; Serajuddin ATM
    Int J Pharm; 2023 Feb; 632():122542. PubMed ID: 36566823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.
    Okwuosa TC; Pereira BC; Arafat B; Cieszynska M; Isreb A; Alhnan MA
    Pharm Res; 2017 Feb; 34(2):427-437. PubMed ID: 27943014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalised paediatric chewable Ibuprofen tablets fabricated using 3D micro-extrusion printing technology.
    Tabriz AG; Nandi U; Scoutaris N; Sanfo K; Alexander B; Gong Y; Hui HW; Kumar S; Douroumis D
    Int J Pharm; 2022 Oct; 626():122135. PubMed ID: 36028083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
    Alhijjaj M; Belton P; Qi S
    Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-Printed Network Structures as Controlled-Release Drug Delivery Systems: Dose Adjustment, API Release Analysis and Prediction.
    Korte C; Quodbach J
    AAPS PharmSciTech; 2018 Nov; 19(8):3333-3342. PubMed ID: 29855799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of novel oral ricobendazole formulation applying melting solidification printing process (MESO-PP): An innovative solvent-free alternative method for 3D printing using a simplified concept and low temperature.
    Real JP; Barberis ME; Camacho NM; Sánchez Bruni S; Palma SD
    Int J Pharm; 2020 Sep; 587():119653. PubMed ID: 32682957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrusion and 3D printing of novel lipid-polymer blends for oral drug applications.
    Tang TO; Holmes S; Boyd BJ; Simon GP
    Biomater Adv; 2022 Jun; 137():212818. PubMed ID: 35929236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-demand manufacturing of immediate release levetiracetam tablets using pressure-assisted microsyringe printing.
    El Aita I; Breitkreutz J; Quodbach J
    Eur J Pharm Biopharm; 2019 Jan; 134():29-36. PubMed ID: 30439504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.